Published in Ned Tijdschr Geneeskd on November 26, 2005
[The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology]. Ned Tijdschr Geneeskd (2006) 0.75
[The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of general practice]. Ned Tijdschr Geneeskd (2005) 0.75
The athlete's heart. A meta-analysis of cardiac structure and function. Circulation (2000) 4.04
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J (1995) 2.21
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res (1988) 2.13
Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction. Eur Heart J (1997) 2.06
Quantification of pulmonary and systemic blood flow by magnetic resonance velocity mapping in the assessment of atrial-level shunts. Int J Card Imaging (1996) 2.04
Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome. Eur Heart J (2000) 1.81
Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology (1993) 1.63
Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart (2004) 1.62
Survival and complication free survival in Marfan's syndrome: implications of current guidelines. Heart (1999) 1.62
Discussing sexual function in the cardiology practice. Clin Res Cardiol (2013) 1.60
Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect. Circulation (2002) 1.60
Non-compaction cardiomyopathy-echocardiographic diagnosis. Eur J Echocardiogr (2002) 1.59
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol (2005) 1.56
Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation (1993) 1.55
Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart (2008) 1.55
Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol (1998) 1.55
A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias. Am Heart J (2002) 1.53
80 years of Netherlands Society of Cardiology. Neth Heart J (2014) 1.53
Immediate thallium-201 reinjection following stress imaging: a time-saving approach for detection of myocardial viability. J Nucl Med (1993) 1.52
Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart (2006) 1.50
Three-dimensional catheter positioning during radiofrequency ablation in patients: first application of a real-time position management system. J Cardiovasc Electrophysiol (2000) 1.50
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2000) 1.48
The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart (2014) 1.43
The additive value of gated SPET myocardial perfusion imaging in patients with known and suspected coronary artery disease. Nucl Med Commun (2001) 1.43
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43
Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients. Int J Cardiol (2007) 1.42
Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation (2007) 1.42
Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping. Radiology (2001) 1.42
Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart (2008) 1.42
Evaluation of a new transcardiac conductance method for continuous on-line measurement of left ventricular volume. Crit Care Med (2000) 1.41
[Screening of asymptomatic individuals for coronary disease using CT-calcium measurement in the coronary arteries]. Ned Tijdschr Geneeskd (2006) 1.40
[Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia]. Ned Tijdschr Geneeskd (2006) 1.40
Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr (1997) 1.39
Evaluation of the incremental diagnostic value and impact on patient treatment of thallium scintigraphy. J Nucl Med (1992) 1.39
Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions. Int J Card Imaging (2000) 1.39
Micro stent, quantitative coronary angiography, and procedural results. Cathet Cardiovasc Diagn (1996) 1.39
Automated measurement of volume flow in the ascending aorta using MR velocity maps: evaluation of inter- and intraobserver variability in healthy volunteers. J Comput Assist Tomogr (1998) 1.37
Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol (1997) 1.33
Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. Am J Cardiol (1996) 1.33
Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol (1993) 1.32
Durrer prizes 2011. Neth Heart J (2012) 1.32
Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation (1998) 1.31
Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology (2000) 1.28
Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications. Am Heart J (1993) 1.27
Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med (1981) 1.27
Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med (1996) 1.26
Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur J Echocardiogr (2004) 1.25
Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation (1997) 1.22
Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol (1988) 1.19
Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation (1999) 1.19
Pulmonary artery root dilatation in Marfan syndrome: quantitative assessment of an unknown criterion. Heart (2002) 1.18
Intracardiac pseudotumor caused by mitral annular calcification. Eur J Echocardiogr (2005) 1.17
Clinical application of CT coronary angiography: state of the art. Heart Lung Circ (2010) 1.17
Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation (1994) 1.17
Arrhythmogenic right ventricular dysplasia: MRI findings. Herz (2000) 1.17
Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol (1990) 1.16
8 October 1958, D Day for the implantable pacemaker. Neth Heart J (2008) 1.16
I-123 labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. A preliminary study. Eur J Nucl Med (1980) 1.15
High survival rate of 43% in out-of-hospital cardiac arrest patients in an optimised chain of survival. Neth Heart J (2015) 1.15
Quantitative assessment of dural ectasia as a marker for Marfan syndrome. Radiology (2001) 1.15
Imaging in cardiac resynchronisation therapy. Neth Heart J (2008) 1.15
Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr (1991) 1.15
Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging (1992) 1.14
Gingival hyperplasia induced by nifedipine, an arterial vasodilating drug. Oral Surg Oral Med Oral Pathol (1985) 1.14
Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med (1981) 1.12
Noninvasive evaluation of aortocoronary bypass grafts with magnetic resonance flow mapping. Am J Cardiol (1995) 1.12
Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non-invasive evaluation with multi-slice computed tomography. Acute Card Care (2007) 1.11
Anatomical and functional imaging techniques: basically similar or fundamentally different? Neth Heart J (2007) 1.11
Quantitation of global and regional left ventricular function by cine magnetic resonance imaging during dobutamine stress in normal human subjects. Eur Heart J (1993) 1.10
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J (2010) 1.10
Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart (1998) 1.10
Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology (1991) 1.10
Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group. J Am Coll Cardiol (1996) 1.09
Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol (2000) 1.09
Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch (2007) 1.08
Quantitative analysis of cardiovascular MR images. Int J Card Imaging (1997) 1.08
Biventricular systolic function and mass studied with MR imaging in children with pulmonary regurgitation after repair for tetralogy of Fallot. Radiology (1996) 1.08
NVVC/NHJ Durrer Prizes 2012. Neth Heart J (2013) 1.08
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol (2004) 1.07
Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost (2001) 1.07
Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart (1998) 1.07
Myocardial infarct size after reperfusion therapy: assessment with Gd-DTPA-enhanced MR imaging. Radiology (1990) 1.06
Neurocardiological differences between musicians and control subjects. Neth Heart J (2013) 1.06
Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris. J Cardiovasc Pharmacol (1991) 1.05
Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation. Neth Heart J (2014) 1.05
Diagnosis and management of anomalous origin of the right coronary artery from the left coronary sinus. Int J Card Imaging (1999) 1.04
Comparison of multiple-dose and once-daily nitrate therapy in 1212 patients with stable angina pectoris: effects on quality of life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group. Angiology (1997) 1.04
Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol (1993) 1.04
Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol (2000) 1.04
Effects of spontaneous and streptokinase-induced recanalization on left ventricular function after myocardial infarction. Circulation (1983) 1.03